Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-05-11 4:06 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | EcoR1 Capital LLC | 3,579,377 8.5% | 3,579,377 (New Position) | View |
2021-04-12 5:45 pm Unchanged | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 7,151,624 26.1% | 0 (Unchanged) | View |
2021-03-10 5:17 pm Purchase | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital LLC | 7,151,624 26.1% | 3,338,300 (+87.54%) | View |
2021-02-16 12:16 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 48,558 0.1% | -4,985,303 (-99.04%) | View |
2021-02-16 12:11 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital LLC | 7,977,702 9.4% | 2,702,702 (+51.24%) | View |
2021-02-16 12:10 pm Purchase | 13G | AVIDITY BIOSCIENCES INC RNA | EcoR1 Capital LLC | 2,103,950 5.6% | 2,103,950 (New Position) | View |
2021-02-16 12:07 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 3,092,218 8.7% | 450,000 (+17.03%) | View |
2021-02-16 12:05 pm Sale | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | EcoR1 Capital LLC | 3,122,704 7.5% | -793,176 (-20.26%) | View |
2021-02-16 12:02 pm Purchase | 13G | MORPHIC HLDG INC MORF | EcoR1 Capital LLC | 2,839,884 9.1% | 685,039 (+31.79%) | View |
2021-02-16 12:00 pm Sale | 13G | KURA ONCOLOGY INC KURA | EcoR1 Capital LLC | 1,773,037 2.7% | -2,468,916 (-58.20%) | View |
2021-02-16 11:58 am Sale | 13G | GERON CORP GERN | EcoR1 Capital LLC | 28,555,310 8.9% | -290,844 (-1.01%) | View |
2021-02-16 11:56 am Purchase | 13G | ATRECA INC BCEL | EcoR1 Capital LLC | 2,426,685 8.1% | 945,274 (+63.81%) | View |
2021-02-16 11:54 am Purchase | 13G | AKOUOS INC AKUS | EcoR1 Capital LLC | 1,975,984 5.7% | 1,975,984 (New Position) | View |
2021-02-16 09:49 am Unchanged | 13G | SAVARA INC SVRA | EcoR1 Capital LLC | 3,040,540 5.3% | 0 (Unchanged) | View |
2021-02-12 5:48 pm Sale | 13G | SAVARA INC SVRA | EcoR1 Capital LLC | 3,040,540 5.3% | -1,432,664 (-32.03%) | View |
2021-02-12 5:33 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | EcoR1 Capital LLC | 600,000 3.6% | -415,400 (-40.91%) | View |
2021-02-12 5:23 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | EcoR1 Capital LLC | 93,416 0.2% | -2,235,076 (-95.99%) | View |
2021-02-12 5:19 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | EcoR1 Capital LLC | 2,298,850 2.1% | -4,597,701 (-66.67%) | View |
2021-02-12 4:15 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | EcoR1 Capital LLC | 3,650,080 5.4% | 1,327,436 (+57.15%) | View |
2021-02-12 4:06 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | EcoR1 Capital LLC | 0 0% | -2,248,306 (Position Closed) | View |